614 related articles for article (PubMed ID: 34075056)
21. Neural HO-1/sterol interactions in vivo: implications for Alzheimer's disease.
Hascalovici JR; Song W; Liberman A; Vaya J; Khatib S; Holcroft C; Laferla F; Schipper HM
Neuroscience; 2014 Nov; 280():40-9. PubMed ID: 25218961
[TBL] [Abstract][Full Text] [Related]
22. The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer's Disease.
Gamba P; Giannelli S; Staurenghi E; Testa G; Sottero B; Biasi F; Poli G; Leonarduzzi G
Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34067119
[TBL] [Abstract][Full Text] [Related]
23. Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?
Griffin JW; Bradshaw PC
Oxid Med Cell Longev; 2017; 2017():5472792. PubMed ID: 28261376
[TBL] [Abstract][Full Text] [Related]
24. Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?
Marwarha G; Ghribi O
Exp Gerontol; 2015 Aug; 68():13-8. PubMed ID: 25261765
[TBL] [Abstract][Full Text] [Related]
25. Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer's Disease.
Staurenghi E; Testa G; Leoni V; Cecci R; Floro L; Giannelli S; Barone E; Perluigi M; Leonarduzzi G; Sottero B; Gamba P
Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671883
[TBL] [Abstract][Full Text] [Related]
26. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
[TBL] [Abstract][Full Text] [Related]
27. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.
Costa AC; Joaquim HPG; Nunes VS; Kerr DS; Ferreira GS; Forlenza OV; Gattaz WF; Talib LL
Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):501-507. PubMed ID: 28861608
[TBL] [Abstract][Full Text] [Related]
28. Imbalanced cholesterol metabolism in Alzheimer's disease.
Xue-Shan Z; Juan P; Qi W; Zhong R; Li-Hong P; Zhi-Han T; Zhi-Sheng J; Gui-Xue W; Lu-Shan L
Clin Chim Acta; 2016 May; 456():107-114. PubMed ID: 26944571
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression.
Jahn T; Clark C; Kerksiek A; Lewczuk P; Lütjohann D; Popp J
J Steroid Biochem Mol Biol; 2021 Jan; 205():105785. PubMed ID: 33171206
[TBL] [Abstract][Full Text] [Related]
30. Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2.
Staurenghi E; Cerrato V; Gamba P; Testa G; Giannelli S; Leoni V; Caccia C; Buffo A; Noble W; Perez-Nievas BG; Leonarduzzi G
Redox Biol; 2021 Feb; 39():101837. PubMed ID: 33360775
[TBL] [Abstract][Full Text] [Related]
31. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol Metabolism in Neurodegenerative Diseases.
He K; Zhao Z; Zhang J; Li D; Wang S; Liu Q
Antioxid Redox Signal; 2024 Jun; ():. PubMed ID: 38842175
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic and Genetic Associations between Alzheimer's Disease, Parkinson's Disease, and Cancer.
Forés-Martos J; Boullosa C; Rodrigo-Domínguez D; Sánchez-Valle J; Suay-García B; Climent J; Falcó A; Valencia A; Puig-Butillé JA; Puig S; Tabarés-Seisdedos R
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203763
[TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
36. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
37. Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics.
Pan Y; Nicolazzo JA
Adv Drug Deliv Rev; 2018 Oct; 135():62-74. PubMed ID: 29665383
[TBL] [Abstract][Full Text] [Related]
38. Oxysterols and Alzheimer's disease.
Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
[TBL] [Abstract][Full Text] [Related]
39. Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier.
Kober AC; Manavalan APC; Tam-Amersdorfer C; Holmér A; Saeed A; Fanaee-Danesh E; Zandl M; Albrecher NM; Björkhem I; Kostner GM; Dahlbäck B; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):573-588. PubMed ID: 28315462
[TBL] [Abstract][Full Text] [Related]
40. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
